Point72 Asset Management L.P. 13D and 13G filings for Syndax Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-01-22 5:50 pm Purchase |
2025-01-21 | 13G | Syndax Pharmaceuticals, Inc. SNDX |
Point72 Asset Management L.P. | 4,277,847 5.000% |
1,443,348 (+50.92%) |
Filing |
| 2024-02-14 07:01 am Sale |
2023-12-31 | 13G | Syndax Pharmaceuticals, Inc. SNDX |
Point72 Asset Management L.P. | 2,834,499 3.300% |
-685,903 (-19.48%) |
Filing |
| 2023-10-31 4:26 pm Purchase |
2023-10-30 | 13G | Syndax Pharmaceuticals, Inc. SNDX |
Point72 Asset Management L.P. | 3,520,402 5.100% |
3,520,402 (New Position) |
Filing |